U.K. Upholds One Lipitor Patent, Invalidates Another
In a decision that both pharmaceutical companies Pfizer and Ranbaxy plan to appeal, a U.K. court has upheld one of Pfizer's patents for billion-dollar drug Lipitor and has ruled another invalid....To view the full article, register now.
Already a subscriber? Click here to view full article